Dermata Therapeutics Inc (DRMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,559 | -12,288 | -7,795 | -9,611 | -7,903 |
| Depreciation Amortization | N/A | N/A | N/A | N/A | 14 |
| Accounts payable and accrued liabilities | -388 | -109 | 369 | -19 | 411 |
| Other Working Capital | -343 | 467 | 864 | -154 | 290 |
| Other Operating Activity | 532 | 766 | 153 | 949 | 1,494 |
| Operating Cash Flow | $-7,758 | $-11,163 | $-6,409 | $-8,834 | $-5,693 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 1,563 |
| Debt Repayment | N/A | N/A | N/A | N/A | -557 |
| Common Stock Issued | 12,168 | 6,886 | 7,606 | 4,277 | 15,386 |
| Other Financing Activity | -50 | 0 | 0 | 0 | -430 |
| Financing Cash Flow | $12,118 | $6,886 | $7,606 | $4,277 | $15,962 |
| Beginning Cash Position | 3,162 | 7,438 | 6,241 | 10,799 | 530 |
| End Cash Position | 7,522 | 3,162 | 7,438 | 6,241 | 10,799 |
| Net Cash Flow | $4,360 | $-4,277 | $1,197 | $-4,558 | $10,268 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,758 | -11,163 | -6,409 | -8,834 | -5,693 |
| Free Cash Flow | -7,758 | -11,163 | -6,409 | -8,834 | -5,693 |